Molecular and Clinical Portrait of HER2-low Invasive Lobular Carcinomas
Lounes Djerroudi(Memorial Sloan Kettering Cancer Center), Anne Vincent‐Salomon(Université Paris Sciences et Lettres), Victor Renault(Fondation Jean Dausset-CEPH), Matthieu Carton(Institut Curie), Céline Callens(Université Paris Sciences et Lettres), Camille Benoist(Université Paris Sciences et Lettres), Yann Kieffer(Inserm), Julien Masliah‐Planchon(Physique des Cellules et Cancers), Laetitia Fuhrmann(Institut Curie), Fatima Mechta‐Grigoriou(Inserm), Gaëlle Pierron(Institut Curie), Toulsie Ramtohul(Université Paris Sciences et Lettres), Ahmad El Sabeh-Ayoun(Université Paris Sciences et Lettres), François‐Clément Bidard(Inserm)
Cited by 6
Related Papers
Early allopolyploid evolution in the post-Neolithic <i>Brassica napus</i> oilseed genome
|Science|2014|2.6k
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
|Cancer Cell|2018|1.7k
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
|Journal of Clinical Oncology|2022|676